171 related articles for article (PubMed ID: 31115187)
1. The propensity of invasive circulating tumor cells (iCTCs) in metastatic progression and therapeutic responsiveness.
Dong H; Tulley S; Zhao Q; Cho L; Chen D; Pearl ML; Chen WT
Cancer Med; 2019 Jul; 8(8):3864-3874. PubMed ID: 31115187
[TBL] [Abstract][Full Text] [Related]
2. Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs).
Pearl ML; Dong H; Tulley S; Zhao Q; Golightly M; Zucker S; Chen WT
Gynecol Oncol; 2015 May; 137(2):229-38. PubMed ID: 25769657
[TBL] [Abstract][Full Text] [Related]
3. Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer.
Friedlander TW; Ngo VT; Dong H; Premasekharan G; Weinberg V; Doty S; Zhao Q; Gilbert EG; Ryan CJ; Chen WT; Paris PL
Int J Cancer; 2014 May; 134(10):2284-93. PubMed ID: 24166007
[TBL] [Abstract][Full Text] [Related]
4. Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer.
Pearl ML; Zhao Q; Yang J; Dong H; Tulley S; Zhang Q; Golightly M; Zucker S; Chen WT
Gynecol Oncol; 2014 Sep; 134(3):581-90. PubMed ID: 24972191
[TBL] [Abstract][Full Text] [Related]
5. Vita-Assay™ Method of Enrichment and Identification of Circulating Cancer Cells/Circulating Tumor Cells (CTCs).
Tulley S; Zhao Q; Dong H; Pearl ML; Chen WT
Methods Mol Biol; 2016; 1406():107-19. PubMed ID: 26820949
[TBL] [Abstract][Full Text] [Related]
6. An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer.
Premasekharan G; Gilbert E; Okimoto RA; Hamirani A; Lindquist KJ; Ngo VT; Roy R; Hough J; Edwards M; Paz R; Foye A; Sood R; Copren KA; Gubens M; Small EJ; Bivona TG; Collisson EA; Friedlander TW; Paris PL
Cancer Lett; 2016 Sep; 380(1):144-52. PubMed ID: 27343980
[TBL] [Abstract][Full Text] [Related]
7. iCTC drug resistance (CDR) Testing ex vivo for evaluation of available therapies to treat patients with epithelial ovarian cancer.
Pearl ML; Dong H; Zhao Q; Tulley S; Dombroff MK; Chen WT
Gynecol Oncol; 2017 Nov; 147(2):426-432. PubMed ID: 28830645
[TBL] [Abstract][Full Text] [Related]
8. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients.
Lu J; Fan T; Zhao Q; Zeng W; Zaslavsky E; Chen JJ; Frohman MA; Golightly MG; Madajewicz S; Chen WT
Int J Cancer; 2010 Feb; 126(3):669-83. PubMed ID: 19662651
[TBL] [Abstract][Full Text] [Related]
9. High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness.
Long E; Ilie M; Bence C; Butori C; Selva E; Lalvée S; Bonnetaud C; Poissonnet G; Lacour JP; Bahadoran P; Brest P; Gilson E; Ballotti R; Hofman V; Hofman P
Cancer Med; 2016 Jun; 5(6):1022-30. PubMed ID: 26945789
[TBL] [Abstract][Full Text] [Related]
10. Assessing Clinical Outcomes in Colorectal Cancer with Assays for Invasive Circulating Tumor Cells.
Zhang Y; Zarrabi K; Hou W; Madajewicz S; Choi M; Zucker S; Chen WT
Biomedicines; 2018 Jun; 6(2):. PubMed ID: 29882767
[TBL] [Abstract][Full Text] [Related]
11. Real-time in vivo imaging of subpopulations of circulating tumor cells using antibody conjugated quantum dots.
Kuo CW; Chueh DY; Chen P
J Nanobiotechnology; 2019 Feb; 17(1):26. PubMed ID: 30728024
[TBL] [Abstract][Full Text] [Related]
12. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
[TBL] [Abstract][Full Text] [Related]
13. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
[TBL] [Abstract][Full Text] [Related]
14. Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.
Paterlini-Bréchot P
Future Oncol; 2011 Jul; 7(7):849-71. PubMed ID: 21732757
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.
Fan T; Zhao Q; Chen JJ; Chen WT; Pearl ML
Gynecol Oncol; 2009 Jan; 112(1):185-91. PubMed ID: 18954898
[TBL] [Abstract][Full Text] [Related]
17. Clinical application of circulating tumor cells in breast cancer.
Broersen LH; van Pelt GW; Tollenaar RA; Mesker WE
Cell Oncol (Dordr); 2014 Feb; 37(1):9-15. PubMed ID: 24249155
[TBL] [Abstract][Full Text] [Related]
18. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer.
Schölch S; García SA; Iwata N; Niemietz T; Betzler AM; Nanduri LK; Bork U; Kahlert C; Thepkaysone ML; Swiersy A; Büchler MW; Reissfelder C; Weitz J; Rahbari NN
Oncotarget; 2016 May; 7(19):27232-42. PubMed ID: 27029058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
